Inotek’s glaucoma lead candidate falls at Phase 3 trial
January 4, 2017Research and Development Glaucoma, inotek, inotek pharma
Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …
Blast at Sun Pharma factory kills two
January 4, 2017Medical Communications, Research and Development Sun Pharma, factory, fire
A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …
Amgen’s patent win upheld against Sanofi-Regeneron
January 4, 2017Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent
In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …
Texas launches lawsuit against FDA over lethal drug shipment
January 4, 2017Medical Communications, Research and Development FDA, texas
The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …
Greek authorities raid Novartis’ offices after bribery allegations
January 4, 2017Medical Communications, Research and Development Greece, Greek, Novartis, bribery
The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …
Sanofi and MSD end their joint vaccines partnership
January 3, 2017Research and Development MSD, Sanofi, Sanofi pasteur msd
With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …
Giovanni Caforio to be made chairman of the board at BMS
January 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb
Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …
Biogen’s gains late-year drug approval first for controversially expensive drug
January 3, 2017Manufacturing and Production, Sales and Marketing Biogen, FDA
The FDA squeezed in one last approval before the year ended with the first approval for a drug to treat …
Four die in Seattle Genetics’ drug trial
January 3, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold
Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …
Sanofi files lawsuit against Novo Nordisk over ‘false allegations’
January 3, 2017Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi
Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …
Sanofi and Boehringer confirm successful exchange of businesses
January 3, 2017Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Sanofi
Sanofi and Boehringer Ingelheim have confirmed the successful completion of the exchange of Sanofi’s animal health business (Merial, based in …
Mylan ends 2016 with spate of generics
January 3, 2017Manufacturing and Production, Sales and Marketing Mylan, generics, launch
Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …
Pfizer announces acquisition of small-molecule business from AZ for $550 million
December 23, 2016Medical Communications AstraZeneca, Pfizer
Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …
French clinical trial tragedy did not check all data
December 23, 2016Medical Communications Bial
There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports …
Teva hit with record fine $519 million corruption fine
December 23, 2016Medical Communications Teva, corruption, fine
Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …
2016 Top markets report
December 23, 2016Medical Communications market, market access
2016 Top Markets Report
Top Ten most popular articles on Pharmafile.com this year
December 23, 2016Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …
Merrimack’s breast cancer trial stutters to halt
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack
Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
Impax Laboratories parts with CEO
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories
Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …
Seven pharma trends for 2017
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing
What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
